Bgi Genomics
BGI Genomics Co Ltd is a Chinese multinational biotechnology and genomic sequencing enterprise specializing in genetic testing, precision medicine, clinical diagnostics, and life science research services. The company provides high-throughput gene sequencing, non-invasive prenatal testing (NIPT), oncology screening, infectious disease detection, and multi-omics research solutions to hospitals, research institutions, and healthcare providers worldwide. Its core business operations encompass genomic sequencing services, clinical diagnostic kit manufacturing, bioinformatics data analysis, and international wholesale distribution. Revenue is derived primarily from genetic testing service fees, diagnostic kit sales, and collaborative research contracts. BGI Genomics holds a dominant global market position in genetic sequencing and clinical genomics. The company is headquartered in Shenzhen, Guangdong Province, China, and its shares trade on the Shenzhen Stock Exchange.
2 of the funds FundTelligence covers report a position in Bgi Genomics.
- Legal name
- Bgi Genomics Co Ltd
- Sector
- Health Care
- Country
- China
- Funds holding it
- 2
Funds holding Bgi Genomics
- Handelsbanken Emerging Markets Index — Handelsbanken · 0.01 % (full portfolio disclosed, September 2026)
- Handelsbanken Global Index Criteria — Handelsbanken · 0.01 % (full portfolio disclosed, September 2026)